✦ LIBER ✦

5167 French cost effectiveness study of the MammaPrint 70-gene signature in early stage breast cancer patients

✍ Scribed by Zarca, D.; Stork-Sloots, L.; de Snoo, F.; Brink, G.; Dervaux, Y.; Boubli, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of the 70-gene signat

✍ Valesca P. Retèl; Manuela A. Joore; Michael Knauer; Sabine C. Linn; Michael Haup 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Economic evaluation of the 70-gene progn

✍ Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Masakazu Toi 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 281 KB

The 70-gene prognosis-signature predicts

✍ Stella Mook; Marjanka K. Schmidt; Giuseppe Viale; Giancarlo Pruneri; Inge Eekhou 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 303 KB

Economic evaluation of the 21-gene signa

✍ Masahide Kondo; Shu-Ling Hoshi; Takeharu Yamanaka; Hiroshi Ishiguro; Masakazu To 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 292 KB

302 Using the 21-gene Breast Cancer Assa

✍ W. Eiermann; M. Rezai; S. Kummel; T. Kuhn; M. Warm; K. Friedrichs; A. Benkow; J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB